Morbidity in 258 Bipolar Outpatients Followed for 1 Year With Daily Prospective Ratings on the NIMH Life Chart Method
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: A number of recent longitudinal outcome studies have found substantial long-term morbidity in patients with bipolar disorder. The detailed course and pattern of illness emerging despite comprehensive treatment with mood stabilizers and adjunctive agents have previously not been well delineated. METHOD: 258 consecutive outpatients admitted from 1996 to 1999 to the Stanley Foundation Bipolar Network who had a full year of prospective daily clinician ratings on the National Institute of Mental Health-Life Chart Method were included in the analysis. Patients were diagnosed by the Structured Clinical Interview for DSM-IV, with the majority (76%) having bipolar I disorder. They completed a questionnaire on demographics and prior illness course, and variables associated with outcome were examined in a hierarchical multinomial logistic regression analysis. Patients were treated naturalistically with a mean of 4.1 psychotropic medications during the year. RESULTS: Despite comprehensive pharmacologic treatment, mean time depressed (33.2% of the year) was 3-fold higher than time manic (10.8%); 62.8% of patients had 4 or more mood episodes per year. Two thirds of the patients were substantially impacted by their illness; 26.4% were ill for more than three fourths of the year, and 40.7% were intermittently ill with major affective episodes. After logistic regression analysis, those who were ill most of the year, compared with the largely well group, had a significantly greater family history of substance abuse, 10 or more depressive episodes, and limited occupational functioning prior to Network entry. CONCLUSION: A majority of outpatients with bipolar illness, even with intense monitoring and treatment in specialty clinics, have a considerable degree of residual illness-related morbidity, including a 3-fold greater amount of time spent depressed versus time spent manic. A personal or family history of substance abuse, 10 or more prior depressions, and limited occupational functioning predicted the poorest outcomes. Additional interventions, particularly those targeted at treating depressive phases of bipolar illness, are greatly needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For many patients with BD, the depressive polarity is often more pervasive and more debilitating than manic states, with estimates that depressed mood accounts for up to two‐thirds of the time spent unwell, even with treatment.12, 223, 224”
Citations
Cites
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Keller, M. B. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180050009 · Cited by 1,643
Manic-Depressive Insanity and Paranoia.
(1921) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1921.02630330070026 · Cited by 1,573
Relapse and impairment in bipolar disorder
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1635 · Cited by 762
Clinical Factors in Lithium Carbonate Prophylaxis Failure
Dunner, D. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760080077013 · Cited by 514
The Stanley Foundation Bipolar Treatment Outcome Network
Suppes, T., Leverich, G. S., Keck, P. E., Nolen, W. A., Denicoff, K. D., Altshuler, L. L., McElroy, S. L., Rush, A. J., Kupka, R., Frye, M. A., et al. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00432-3 · Cited by 484
Self-citationKeck, P. E., McElroy, S. L., Strakowski, S. M., West, S. A., Sax, K. W., Hawkins, J. M., Bourne, M. L., & Haggard, P. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.5.646 · Cited by 455
Self-citationComparison of Standard and Low Serum Levels of Lithium for Maintenance Treatment of Bipolar Disorder
Gelenberg, A. J., Kane, J. M., Keller, M. B., Lavori, P., Rosenbaum, J. F., Cole, K., & Lavelle, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911303212201 · Cited by 448
The Classification of Depressions: A Review of Contemporary Confusion
Kendell, R. E. (1976) · British Journal of Psychiatry · doi:10.1192/bjp.129.1.15 · Cited by 385
Cited by
Items 301–400 of 420
Unipolare Depression – Pharmakotherapie und Psychotherapie (ICD-10 F3)
Schmauß, M., Schramm, E., & Berger, T. (2009) · Elsevier eBooks · doi:10.1016/b978-3-437-24900-6.50011-3 · Cited by 5
The course of bipolar disorder in pregnant versus non-pregnant women
Stevens, A. W. M. M., Draisma, S., Goossens, P. J. J., Broekman, B. F. P., Honig, A., der Klein, E. A. M. K.-V., Nolen, W. A., Post, R. M., & Kupka, R. (2021) · International Journal of Bipolar Disorders · doi:10.1186/s40345-021-00239-z · Cited by 5
“determined the severity of illness in the first 258 outpatients in the SFBN who had 1 year of prospective LCM ratings (Post et al. 2003).”
Self-citationTreatment of Bipolar Depression
Post, R. M., Baldassano, C. F., Perlis, R. H., & Ginsberg, D. L. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-435-7_5 · Cited by 5
Self-citationBaldessarini, R. J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3710-9_3 · Cited by 9
Challenges in the development of treatment guidelines for bipolar disorder
Fountoulakis, K. Ν., Fountoulakis, N. K., & Antoniadis, D. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1564004 · Cited by 5
Novis, F. D., Cirillo, P., da Silva, R. D. A., Santos, A. L., Silveira, L. A. S., Cardoso, A., Coscarelli, P. G., Nardi, A. E., & Cheniaux, E. (2014) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2012-0048 · Cited by 6
Health-related quality of life in Thai bipolar disorder.
Kongsakon, R., Thomyangkoon, P., Kanchanatawan, B., & Janenawasin, S. (2008) · PubMed · Cited by 4
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_3 · Cited by 5
Molecular Architecture and Neurobiology of Bipolar Disorder
Bearden, C. E., Zandi, P. P., & Freimer, N. B. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00030-5 · Cited by 5
Chen, S.-Y., Chen, C., Lo, C., Lu, M., Hsu, C.-D., Chiu, Y.-H., Chen, C.-H., Lin, S., Huang, M., Chen, H., et al. (2021) · Nature and Science of Sleep · doi:10.2147/nss.s301357 · Cited by 4
Algorithm-driven treatment for bipolar disorder in Korea: Clinical feasibility, efficacy, and safety
Jon, D., Bahk, W., Yoon, B.-H., Min, K. J., Shin, Y. C., Cho, H. S., Kwon, J. S., Lee, E. M., & Kim, C. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500802559389 · Cited by 5
Fuller, M. A. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_34 · Cited by 4
Polaridad predominante en pacientes bipolares tipo I
Obando, A. C. T., García, Á. M. A., Rodríguez, M. A. G., Palacio, T. F. R., Ontoso, M. S., Tamayo, A., & Jaramillo, C. A. L. (2012) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(14)60050-0 · Cited by 5
“Edad de inicio 24,7 (7-56) 23,7 (7-55) 25,5 (13-38) 27,15 (11-56)”
BackgroundInfluentialNeuropsychological performance, emotion processing and psychosocial function in bipolar disorder
Robinson, L. J. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 5
Pharmacological treatment of bipolar depression
Young, A. H., & Nemeroff, C. B. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511776922.004 · Cited by 3
Tamayo, J. M. (2011) · Actas Españolas de Psiquiatría · Cited by 5
Psychotrophic Mechanisms of Action of Antiepileptic Drugs in Mood Disorder
Post, R. M. (2008) · Medical psychiatry · doi:10.3109/9780849382666.021 · Cited by 3
Self-citationBipolar Disorder Patient Care Opportunities: Let's Answer the Call
Caley, C. F. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1m432 · Cited by 3
Atypical and typical antipsychotics in the schools
Noggle, C. A., & Dean, R. S. (2009) · Psychology in the Schools · doi:10.1002/pits.20427 · Cited by 3
Comorbid Substance Abuse Affects Treatment for Bipolar Disorder
Lawson, W. B., & Bland, W. P. (2004) · Psychiatric Annals · doi:10.3928/0048-5713-20040101-09 · Cited by 3
Ushkalova, A., Kostyukova, E. G., & Mosolov, S. N. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20151151223-30 · Cited by 5
“У больных БАР I симптомы депрессии наблюдаются в 3—4 раза чаще, чем симптомы мании [4], а у пациентов с БАР II — в 39 раз чаще, чем симптомы гипомании [5, 6].”
Fountoulakis, K. N. (2014) · Springer eBooks · doi:10.1007/978-3-642-37216-2_15 · Cited by 3
Polypharmazie in der Behandlung bipolarer Störungen
Grunze, H., Forsthoff, A., & Born, C. (2006) · Springer eBooks · doi:10.1007/3-211-31221-8_3 · Cited by 4
Pharmacotherapy for Bipolar Depression: A Review of the Evidence
Aarre, T. F., & Dahl, A. A. (2008) · Current Psychiatry Reviews · doi:10.2174/157340008785829913 · Cited by 3
“Longitudinal studies have shown that while episodes of mood elevation are present for nearly 10% of the follow-up time, depressive symptoms of varying degrees are present for about 30% of the time [1, 2].”
BackgroundDiagnostic Criteria and Epidemiology of Bipolar Disorders
Morton, E. E., & Murray, G. (2024) · Springer eBooks · doi:10.1007/978-3-031-63349-2_2 · Cited by 3
Feng, L., Wang, W., Yin, C., Li, J., Zhang, X., Chang, X., Feng, Z., Zandt, M. V., You, S. C., Seager, S. L., et al. (2025) · Health Data Science · doi:10.34133/hds.0209 · Cited by 2
“Second, most patients with bipolar disorder spent the majority of their course in depressive episodes, and depressive symptoms had more significant negative impacts on psychosocial functioning and suicide risk than hypomanic/manic symptoms [ 7 , 46 – 48 ].”
Pharmacological Management of Treatment‐Resistant Unipolar Depression
McGrath, P. J., & Miller, J. M. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch112 · Cited by 2
Afshari, B. (2023) · Exploration of neuroscience · doi:10.37349/en.2023.00032 · Cited by 2
A Magnetic Resonance Spectroscopy Study on Polarity Subphenotypes in Bipolar Disorder
Argyropoulos, G. D., Christidi, F., Karavasilis, E., Bede, P., Velonakis, G., Antoniou, A., Seimenis, I., Kelekis, N., Smyrnis, N., Papakonstantinou, O., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14111170 · Cited by 2
“Delayed diagnosis of BD is often associated with prolonged periods of destabilization, residual symptoms, increased psychosocial morbidity [18], and development of treatment resistance [19,20].”
BackgroundYang, J., Duan, Z., Zhang, Y., He, W., Li, Q., Pei, Z., Yang, H., & Yan, J. (2024) · Acta Psychologica · doi:10.1016/j.actpsy.2024.104381 · Cited by 2
Perlis, R. H., Ostacher, M. J., & Kapson, H. S. (2003) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629387 · Cited by 2
“Moreover, greater levels of residual symptoms appear to limit patient quality of life and may impair functioning even between episodes [ 23 ].”
BackgroundVivir con un trastorno bipolar. ¿Qué opinan los pacientes?
Sierra, P. (2007) · Dialnet (Universidad de la Rioja) · Cited by 3
The Impact of Psychotropic Drugs on Psychosocial Functioning in Bipolar Disorder
Aydemır, Ö., Aydın, P. Ç., Oyeckin, D. G., Gülseren, Ş., Putgül, G., & Sahin, H. (2014) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20140123034729 · Cited by 2
Evaluating Sorensen’s Therapy for Instability in Mood (STIM) in the case of bipolar disorder
Gutierrez, M. J., Sorensen, J., & Tomlinson, E. (2011) · Europe’s Journal of Psychology · doi:10.5964/ejop.v7i2.133 · Cited by 2
The impact of substance abuse on the severity of manic relapse in bipolar disorder
ElGhonemy, S. H., Fakhry, H., Shafei, A. E., Hussein, H., & Mohamed, O. (2014) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000452970.82711.b8 · Cited by 3
Treating Bipolar Disorder in the Primary Care Setting: The Role of Aripiprazole
Manning, J. S., & McElroy, S. L. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.08r00635 · Cited by 2
Self-citationUnderstanding the neurobiology of bipolar depression
Wang, J.-F., & Young, L. T. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_6 · Cited by 1
A five year follow-up study of 11 patients with bipolar disorder
Novis, F. D., Cheniaux, E., Landeira-Fernández, J., & Versiani, M. (2010) · Jornal Brasileiro de Psiquiatria · doi:10.1590/s0047-20852010000300008 · Cited by 1
Introduction: the burden of bipolar depression.
Bowden, C. L. (2005) · PubMed · Cited by 7
Behandlung bipolarer Störungen
Grunze, H., Grunze, A., & Born, C. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1849-8_3 · Cited by 1
A Procedure to Graph the Quality of Psychosocial Functioning Affected by Symptom Severity
McCullough, J. P., Clark, S. W., Klein, D. N., & First, M. B. (2016) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.2016.70.2.222 · Cited by 1
Antidepressants and Suicide Risk: A Challenge
Pompili, M., Giordano, G., & Lamis, D. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-26282-6_24 · Cited by 1
Pharmacological Treatment of Bipolar Depression
Young, A. H., & Nemeroff, C. B. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch23 · Cited by 1
Bauer, M., Severus, E., & Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_68 · Cited by 1
Chauhan, K. B., Kantak, A. S., Unadkat, K. M., Panchal, B. N., & Vala, A. (2022) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v13i12.47372 · Cited by 1
Johnson, S. L., & Miklowitz, D. J. (2018) · Wiley eBooks · doi:10.1002/9781394258970.ch7 · Cited by 1
Acute Mania and Bipolar Affective Disorder
Sajatovic, M., Herrmann, N., & Shulman, K. I. (2010) · Wiley eBooks · doi:10.1002/9780470669600.ch93 · Cited by 1
Treatment of Bipolar Disorder in Old Age
Shulman, K. I., Herrmann, N., & Sajatovic, M. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch18 · Cited by 1
Long-term management of patients with bipolar disorder
González-Pinto, A. M., & Villamor, A. (2007) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000224798.82394.12 · Cited by 1
“…possibly anxiety, are being recognized increasingly as major sources of residual morbidity, comorbidity, dysfunction, and premature mortality among treated BD patients (Judd et al., 2002; Post et al., 2003; Tondo et al., 2003; Joffe et al., 2004; Baethge et al., 2005; González-Pinto et al., 2006).”
BackgroundSoares, M. B. D. M., Brietzke, E. M., Dias, R. D. S., Mendonca, T., Moreira, C. L. R. L., & Lafer, B. (2010) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2010.00496.x · Cited by 1
“Bipolar depression is the most notable aspect of bipolar disorder (BD) as bipolar patients experience depressive symptoms three times more frequently than manic symptoms during their lifetime (1).”
BackgroundKeßler, U. (2014) · NVA (Nasjonalt vitenarkiv) · Cited by 2
Hypocortisolism in recurrent affective disorders
Maripuu, M. (2015) · DiVA at Umeå University (Umeå University) · Cited by 1
Prevalence of Bipolar Depression
Post, R. M. (2003) · CNS Spectrums · doi:10.1017/s1092852900028765 · Cited by 1
Self-citationEmerging Therapies for Bipolar Depression
Marangell, L. B., Kupfer, D. J., Sachs, G. S., & Swann, A. C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0718 · Cited by 1
“Kupfer then explained that it is important to recognize and treat bipolar depression because it is about 3 times more pervasive than mania.(4) The mean duration of depressive episodes in bipolar disorder is longer than that of manic episodes and becomes chronic in about 20% of patients.”
BackgroundEasing the Burden of Bipolar Disorder: From Urgent Situations to Remission
(2008) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.v10n0507 · Cited by 1
“1 psychotropic medications was taken.(78) Atypical antipsychotics are increasingly added to mood stabilizers early in treatment for breakthrough mania.”
BackgroundStevens, A. W. M. M. (2023) · doi:10.5463/thesis.366 · Cited by 1
Recognition, comorbidity, and outcome of DSM-IV bipolar I and II disorders in psychiatric care
Mantere, O. (2007) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 1
Clinical Psychopharmacology and Other Somatic Therapies
Perry, P. J., Wehring, H. J., ALEXANDER, B. K., & Liskow, B. I. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_34 · Cited by 1
ABORDAJE INTEGRAL DEL TRASTORNO BIPOLAR
González, A. M., Arrillaga, P., Barbeito, S., & Perez, P. V. (2010)
Innovation in the Treatment of Bipolar Depression
El‐Mallakh, R. S. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14com09351
Managing Depression in Primary Care
Culpepper, L., & Johnson, P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-435-7_10
Efectividad de la ketamina en depresión bipolar: revisión sistemática de la literatura
Guerrero, J. E. R., & Ceicedo, A. P. S. (2013) · Repositorio Institucional E-DocUR (Universidad Del Rosario) · doi:10.48713/10336_4840
Kapitel 7 – Unipolare Depression–Pharmakitherapie und Psychotherapie (ICD-10 F3)
Schmauss, M., Schramm, E., & Berger, M. (2007) · Elsevier eBooks · doi:10.1016/b978-343724780-4.50011-7 · Cited by 5
Frangou, S. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.027
Complex Combination Therapy for Long‐Term Stability in Bipolar Disorder
Post, R. M. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch14 · Cited by 2
Self-citationCognitive functioning and its heritability in bipolar I disorder
Antila, M. (2011) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 1
Children in Foster Care and Excessive Medications
Littrell, J. L. (2012) · Digital Archive @ GSU
Bipolar Disorder: not only in the Brain - immunological aspects
Knijff, E. M. (2006) · RePub (Erasmus University Rotterdam)
Bipolar disorder: Strategies for the lifelong illness
Swann, A. C. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629388
Can a Diagnosis Be Epidemic, With Therapeutic Efforts the Catastrophe?
Littrell, J. L. (2012) · Ethical Human Psychology and Psychiatry · doi:10.1891/1559-4343.14.2.91
“Post et al. (2003) found that 62.8% of persons experienced four or more mood episodes per year.”
InfluentialGoodwin, G. M. (2005) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2005.09.007
Keßler, U., Schoeyen, H. K., Vaaler, A., Ødegaard, K. J., Bergsholm, P., Andreassen, O. A., Malt, U. F., & Morken, G. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)70268-6
Benkert, O., Hautzinger, M., Graf-Morgenstern, M., Paulzen, M., & Himmerich, H. (2016) · Springer eBooks · doi:10.1007/978-3-662-49092-1_15
de Arce, R., Jiménez‐Arriero, M. Á., Rodríguez-Calvin, J. L., Ruiz-Aguado, J. M., Domingo, S. Z., Cobaleda, S., & Vieta, E. (2011) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(14)60192-x · Cited by 2
“Many patients diagnosed with BD, despite receiving appropriate treatment and follow-up, may spend up to a third of the year suffering from depressive symptoms (6).”
BackgroundGoossens, P. J. J. (2008) · Radboud Repository (Radboud University)
Adult attachment and coping style in students with elevated mood
Caldwell, L. E. (2014) · Staffordshire Online Repository (Staffordshire University)
A REVIEW REGARDING THE EVOLUTION OF BIPOLAR DISORDER
Ienciu, M., Dehelean, L., Papava, S., & Giurgi-Oncu, C. (2011)
La Quetiapina nel trattamento della depressione bipolare
Camilleri, V., & Mauri, M. C. (2005) · CINECA IRIS Institutial research information system (University of Pisa)
Marcadores biológicos e nível de funcionalidade em pacientes bipolares
Rosa, A. R. (2007) · Lume (Universidade Federal do Rio Grande do Sul)
A systematic review on agomelatine
Fornaro, M. (2009) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology
34 Psychopharmacology and Other Somatic Therapies
Perry, P. J., Wehring, H. J., ALEXANDER, B. K., & Liskow, B. I. (2008)
Laux, G., & Bauer, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_56
Bipolar disorder and alcohol: double trouble of just co-occurence?
van Zaane, J. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 1
Pródromos e estados de risco para transtorno bipolar: oportunidades para prevenção
Noto, M. N., Rios, A. C., Pedrini, M., & Brietzke, E. M. (2016) · Debates em Psiquiatria · doi:10.25118/2236-918x-6-5-4
Epidemiological studies of medication use and effectiveness in bipolar disorder
Wingård, L. (2017) · Figshare
Advancing the study of quality of life in bipolar disorder: A multimethod approach
Morton, E. E. (2018) · Figshare · doi:10.25916/sut.26279554
Michelon, L. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2019.tde-25102019-131555 · Cited by 1
Mood-related Differences in Cerebral Blood Flow in Adolescents with Bipolar Disorder
Toma, S. (2019) · TSpace (University of Toronto)
An Investigation of Positive and Negative Sleep Appraisals along the Mood Continuum
Pearson, L. (2020) · Research Explorer (The University of Manchester) · Cited by 1
Sória, L. D. S. (2011) · Lume (Universidade Federal do Rio Grande do Sul)
Envolvimento do dano ao DNA e estresse oxidativo no transtorno bipolar e no uso de metilfenidato
Andreazza, A. C. (2008) · Americanae (AECID Library) · Cited by 1
Polypharmazie in der Behandlung bipolarer Störungen
Grunze, H., Forsthoff, A., & Born, C. (2009) · Springer eBooks · doi:10.1007/978-3-211-79826-3_3
(2015) · Dunod eBooks · doi:10.3917/dunod.mirab.2015.01.0314
Lam, D. H., Jones, S. H., & Hayward, P. (2010) · Wiley eBooks · doi:10.1002/9780470970256.refs
Laux, G. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_56
Bauer, M., Severus, E., & Laux, G. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_68-1
Bipolar Disorders: Antipsychotic Drug Therapy of Aripiprazole an Open Label Study
Alecto, A. (2018) · Neuroscience and Neurological Surgery · doi:10.31579/2578-8868/156
Metadata
- Authors
- Post, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Rush, A. J., Keck, P. E., McElroy, S. L., Luckenbaugh, D. A., Pollio, C., Kupka, R., & Nolen, W. A.
- Affiliations
- National Institutes of Health (US)
- University of California, Los Angeles (US)
- The University of Texas Southwestern Medical Center (US)
- University of Cincinnati (US)
- Utrecht University (NL)
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2003-06-15
- Volume
- 64
- Issue
- 6
- Pages
- 680-690
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1965632145
- Cited by
- 418
- References
- 34
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 8 · 2021: 4 · 2020: 9 · 2019: 10 · 2018: 8 · 2017: 16 · 2016: 24 · 2015: 18 · 2014: 24 · 2013: 14 · 2012: 19
- FWCI
- 15.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Funders
- National Institute of Mental Health (R01MH079261)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- bipolar disorder, bipolar I disorder, long-term morbidity, mood episodes, depressive episodes, clinical course, mood stabilizers, occupational functioning, treatment outcome predictors, outpatients
- MeSH terms
- Adult, Ambulatory Care, Bipolar Disorder, Depressive Disorder, Employment, Family, Female, Humans, Male, Middle Aged, Prospective Studies, Psychiatric Status Rating Scales, Psychotropic Drugs, Recurrence, Regression Analysis, Risk Factors, Social Adjustment, Treatment Outcome, Sickness Impact Profile, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.